Navigation Links
Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis

sma-derived protein market is estimated to reach US$8.5 billion by 2010. The North American market was estimated at US$2.4 billion in 2006. Immunoglobulin is the biggest selling protein in North America, with sales estimated at US$1.4 billion in 2006 in the United States alone. Immunoglobulin is used to treat immunological, neurological and other disorders. Plasminogen, once converted into plasmin, is a clot buster and offers a natural alternative to synthesized solutions to address an unmet need of the market. A1PI is used by patients suffering from hereditary emphysema resulting from A1PI deficiency. A1PI deficiency affects between 60,000 to 100,000 people in the United States.

According to Cowen and Company, enzyme replacement therapies (ERTs) will reach US$3.1B in 2011. ERTs are the cornerstone of treatment of many orphan disorders, particularly the lysosomal storage diseases. Orphan diseases are comprised of number different conditions that each afflict only a small number of individuals, but together constitute one of the most lucrative therapeutic areas. The four leading lysosomal disorder products are intended to treat Gaucher's disease, Fabry's disease, Hurler's disease and Pompe's disease.

In 2006, estimated sales for these four leading lysosomal disorder products were US$1 billion, US$359 million, US$96 million and US$30 million respectively, nearly US$1.5 billion in total. Haemacure has identified in its plasma discard enzymes each treating one of these diseases. The enzymes are alpha-galactosidase, used to treat Fabry's disease, alpha-glucosidase, used to treat Pompe's disease, beta-glucosidase, used to treat Gaucher's disease, and alpha-iduronidase, used to treat Hurler's disease.

Haemacure has also identified three other enzymes, used to treat Hunter's disease, Morquio's disease and Shindler's disease. Products are also in development for these diseases.

As advised, these findings are preliminary and the full value of these
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the ...  Sony will be exhibiting and taking orders for this ... the San Diego Convention Center ... May 20 - 22.  The SP6800 ... audio-visual technologies into new and novel functionalities for the ...
(Date:5/17/2013)... BOSTON , May 17, 2013  TechAtlas ... update for their competitive landscape map for the ... highlights over 90 international companies with drugs and ... addressing CKD and its sequelae. ... include: , hypertension - renal denervation ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... Solutions Development Company (MSDC), www.msdrx.com , will present ... Diabetes (EASD) annual conference in Stockholm, Sweden on Sept. ... candidate, MSDC-0160, promotes the proliferation of stem cells that ... brown fat.  The research was conducted in tissue cultures ...
... Canon Communications LLC today announced that it ... Limited, a leading global business media company.  The agreement ... company of Canon Chairman and CEO Charles G. McCurdy, and ... and Spectrum acquired Canon in 2005. "The last ...
Cached Medicine Technology:Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 3
(Date:5/18/2013)... 18, 2013 The Communities of Distinction ... places we call home. These are the townships, villages and ... the locations where the people are friendly and neighbors are ... off the highways and shares the best in both the ... with an American sports and film celebrity. It airs in ...
(Date:5/18/2013)... New York, NY (PRWEB) May 18, 2013 ... of consistent efforts, SizeItUp formally announced the integration ... The redesigned 2012 Hyundai Genesis is set to stun the ... comfort and style. 2012 Hyundai Genesis is marked as the ... database and heads the vehicles lined up for the year ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 As ... in courts throughout the country, Bernstein Liebhard LLP notes ... replacement patients often suffer tissue damage before they experience ... which according to Science Daily will appear in the ... replacement recipients underwent MRI screens of their hips. ...
(Date:5/18/2013)... May 18, 2013 Simple changes in ... healthy snacks and drinking more water can lead to ... ultimately, a healthier lifestyle overall. Diet Doc ... best weight loss can be difficult and often requires ... diet plans to help patients get over initial weight ...
(Date:5/18/2013)... Florida (PRWEB) May 18, 2013 Adolescents, ... also known as “Spice” or “K2” are landing in ... helping to curb this drug epidemic with a ... synthetic marijuana. , According to research from the National ... second-most popular illegal drug among American teenagers. In 2012, ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2
... More than half taking naftidrofuryl, a blood vessel ... 14 (HealthDay News) -- The prescription drug naftidrofuryl ... and enables patients to walk farther, according to ... 1,266 people with the painful condition called intermittent ...
... might add to traditional risk factors , , WEDNESDAY, May 14 ... predicted the risk of death from cardiovascular disease in a ... just a preliminary finding in a long process that might ... in addition to well-established risk factors such as high blood ...
... May 14 Learning about life, health,disability and ... LIFE Foundation unveiled a significantly enhanced version of ... Web address at, http://www.lifehappens.org . The LIFE site ... with objective, easy-to-understand educational,content on all the major ...
... Proposals Reflect Ideas Championed by NCPA,s Family Policy ... embarked,in a new direction aimed at helping working ... Representatives announced a slate of legislation aimed,at simplifying ... laws. The,legislation, titled the American Families Agenda, contains ...
... are estimated to be affected by the devastation caused ... by researchers from the Johns Hopkins Bloomberg School of ... Systems (GIS), the researchers calculated the likely distribution of ... developed maps of the regions at greatest risk from ...
... Offers Precision Laser Technology for Custom Contouring of Women,s ... ... Syneron,s LipoLite, an FDA approved,minimally invasive procedure used to liquefy and remove ... United States at Ariana,Cosmetic Surgery & Laser Center in Las Vegas. LipoLite ...
Cached Medicine News:Health News:Common Drug Eases Leg Pain From Walking 2Health News:Biomarkers Predict Heart Deaths 2Health News:Biomarkers Predict Heart Deaths 3Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 2Health News:LIFE Foundation Launches Lifehappens.org to Help Consumers Make Smart Insurance-Buying Decisions 3Health News:New Initiatives Provide Flexibility, Fairness for Families 2Health News:Estimated 3.2 million Burmese potentially affected by cyclone 2Health News:Las Vegas Plastic Surgeons First in U.S. to Offer LipoLite 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: